|
US20030190740A1
(en)
|
1998-10-13 |
2003-10-09 |
The University Of Georgia Research Foundation, Inc |
Stabilized bioactive peptides and methods of identification, synthesis, and use
|
|
BR9914519A
(pt)
|
1998-10-13 |
2001-07-03 |
Univ Georgia Res Found |
Peptìdios bioativos estabilizados e métodos de identificação, sìntese e uso
|
|
US20040001827A1
(en)
*
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
|
ES2270893T3
(es)
|
1999-12-24 |
2007-04-16 |
Genentech, Inc. |
Procedimiento y composiciones para prolongar la vida media de compuestos bioactivos.
|
|
US20050287153A1
(en)
*
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
DE10012120A1
(de)
*
|
2000-03-13 |
2001-09-27 |
Ktb Tumorforschungs Gmbh |
Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel
|
|
DE50112802D1
(de)
*
|
2000-11-08 |
2007-09-13 |
Fresenius Medical Care Affina |
Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
|
|
CA2440582A1
(en)
|
2001-03-09 |
2002-10-03 |
Dyax Corp. |
Serum albumin binding moieties
|
|
US20030157561A1
(en)
*
|
2001-11-19 |
2003-08-21 |
Kolkman Joost A. |
Combinatorial libraries of monomer domains
|
|
US20050271663A1
(en)
*
|
2001-06-28 |
2005-12-08 |
Domantis Limited |
Compositions and methods for treating inflammatory disorders
|
|
US20110045005A1
(en)
|
2001-10-19 |
2011-02-24 |
Craig Crowley |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
US6916904B2
(en)
*
|
2002-04-24 |
2005-07-12 |
Zolaris Biosciences, Llc |
Inhibition of immune complex formation
|
|
US20050276812A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Antibody-drug conjugates and methods
|
|
US20090068178A1
(en)
*
|
2002-05-08 |
2009-03-12 |
Genentech, Inc. |
Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
|
|
WO2003106493A1
(en)
*
|
2002-06-14 |
2003-12-24 |
Dyax Corporation |
Protein analysis
|
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
EP1517921B1
(en)
*
|
2002-06-28 |
2006-06-07 |
Domantis Limited |
Dual specific ligands with increased serum half-life
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
WO2004041862A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US7329725B1
(en)
|
2003-10-29 |
2008-02-12 |
Nastech Pharmaceutical Company Inc. |
Phage displayed Trp cage ligands
|
|
KR100956913B1
(ko)
|
2003-12-19 |
2010-05-11 |
제넨테크, 인크. |
치료제로서 유용한 일가 항체 단편
|
|
US8754031B2
(en)
|
2004-03-08 |
2014-06-17 |
Oncolix, Inc. |
Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
|
|
EP1730170B1
(en)
*
|
2004-03-10 |
2020-02-19 |
Trinity Therapeutics, Inc. |
Method for inhibiting immune complex formation in a subject
|
|
AU2011253771B2
(en)
*
|
2004-03-10 |
2013-10-31 |
Trinity Therapeutics, Inc. |
Method for inhibiting immune complex formation in a subject
|
|
JP5634008B2
(ja)
*
|
2004-04-06 |
2014-12-03 |
アフィボディ・アーベー |
新規の使用および方法
|
|
TW200607523A
(en)
*
|
2004-06-01 |
2006-03-01 |
Domantis Ltd |
Drug compositions, fusions and conjugates
|
|
AU2005267720B2
(en)
|
2004-08-05 |
2012-02-23 |
Genentech, Inc. |
Humanized anti-cmet antagonists
|
|
KR101270829B1
(ko)
|
2004-09-23 |
2013-06-07 |
제넨테크, 인크. |
시스테인 유전자조작 항체 및 접합체
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
EP1817059A2
(en)
|
2004-12-01 |
2007-08-15 |
Genentech, Inc. |
Conjugates of 1,8-bis-naphthalimides with an antibody
|
|
RU2007119989A
(ru)
*
|
2004-12-02 |
2009-01-10 |
Домантис Лимитед (Gb) |
Композиции, слитые конструкции и конъюгаты plad домена
|
|
JP5185624B2
(ja)
|
2004-12-02 |
2013-04-17 |
ドマンティス リミテッド |
血清アルブミンおよびｇｌｐ−１またはｐｙｙを標的とする二重特異性抗体
|
|
WO2006059108A2
(en)
*
|
2004-12-02 |
2006-06-08 |
Domantis Limited |
ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES
|
|
RU2464276C2
(ru)
|
2005-05-18 |
2012-10-20 |
Аблинкс Н.В. |
Улучшенные нанотела против фактора некроза опухоли-альфа
|
|
DE102005023617A1
(de)
|
2005-05-21 |
2006-11-23 |
Aspre Ag |
Verfahren zum Mischen von Farben in einem Display
|
|
JP5329961B2
(ja)
*
|
2005-09-06 |
2013-10-30 |
トリニティー セラピューティクス インコーポレイテッド |
免疫介在性神経疾患を治療するための方法
|
|
EP1940880A2
(en)
*
|
2005-10-14 |
2008-07-09 |
Novo Nordisk A/S |
Treating diabetes using inhibitors of il-1
|
|
EP1957540B1
(en)
|
2005-12-02 |
2012-06-13 |
Genentech, Inc. |
Binding polypeptides and uses thereof
|
|
US7704953B2
(en)
*
|
2006-02-17 |
2010-04-27 |
Mdrna, Inc. |
Phage displayed cell binding peptides
|
|
WO2007104789A2
(en)
|
2006-03-15 |
2007-09-20 |
Novo Nordisk A/S |
Amylin derivatives
|
|
CL2007001536A1
(es)
|
2006-05-30 |
2008-01-25 |
Genentech Inc |
Anticuerpos anti-cd22; polinucleotidos que los codifica; vector y celula huesped que los comprende; metodo de fabricacion; metodo de deteccion del anticuerpo en una muestra biologica; inmunoconjugado que comprende al anticuerpo; composicion que lo comprende y su uso para tratar trastornos proliferativos de celulas b.
|
|
AU2007306340A1
(en)
*
|
2006-10-11 |
2008-04-17 |
Ablynx N.V. |
Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and use thereof
|
|
EP2061814B1
(en)
|
2006-10-27 |
2012-06-06 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
JP2010512734A
(ja)
*
|
2006-12-13 |
2010-04-30 |
アブリンクス エン．ヴェー． |
Ｉｌ−６／ｉｌ−６受容体複合体等受容体介在性シグナル伝達に関与する複合体に特異的なポリペプチド
|
|
AU2007336242B2
(en)
|
2006-12-19 |
2012-08-30 |
Ablynx N.V. |
Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
AU2007336243B2
(en)
|
2006-12-19 |
2012-07-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
WO2012130874A1
(en)
|
2011-03-28 |
2012-10-04 |
Ablynx Nv |
Bispecific anti-cxcr7 immunoglobulin single variable domains
|
|
HUE029445T2
(en)
|
2006-12-19 |
2017-02-28 |
Genentech Inc |
VEGF-specific antagonists for adjuvant and neoadjuvant therapy and treatment of early-stage tumors
|
|
US9512236B2
(en)
|
2006-12-19 |
2016-12-06 |
Ablynx N.V. |
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
KR20090114443A
(ko)
|
2007-02-09 |
2009-11-03 |
제넨테크, 인크. |
항-Ｒｏｂｏ４ 항체 및 그의 용도
|
|
CL2008002083A1
(es)
|
2007-07-16 |
2008-11-21 |
Genentech Inc |
Anticuerpo humanizado anti-cd79b/igbeta/b29; inmunoconjugado; metodo in vitro para determinar presencia de cd79b, inhibir crecimiento de celula con cd79b, o para detectara celula b; metodo para elaborar dicho anticyerpo humanizado; acido nucleico; celula huesped; composicion; metodo de elaboracion de inmunoconjugado; uso medico
|
|
NZ583367A
(en)
|
2007-07-16 |
2012-10-26 |
Genentech Inc |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
|
AU2008281913B2
(en)
|
2007-07-31 |
2013-11-07 |
Affibody Ab |
New albumin binding compositions, methods and uses
|
|
EP2036923A1
(en)
*
|
2007-09-11 |
2009-03-18 |
Novo Nordisk A/S |
Improved derivates of amylin
|
|
JP5592792B2
(ja)
|
2007-09-26 |
2014-09-17 |
ユセベ ファルマ ソシエテ アノニム |
二重特異性抗体の融合体
|
|
KR100920729B1
(ko)
*
|
2007-10-01 |
2009-10-07 |
한국생명공학연구원 |
펩타이드 혼성체를 사용한 배향성이 조절된 항체단분자막의 제조방법
|
|
CN101970490A
(zh)
|
2007-11-27 |
2011-02-09 |
埃博灵克斯股份有限公司 |
针对异二聚体细胞因子和/或其受体的氨基酸序列以及包括所述氨基酸序列的多肽
|
|
ES2643239T3
(es)
|
2008-01-31 |
2017-11-21 |
Genentech, Inc. |
Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
|
|
WO2009124931A2
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Amino acid sequences directed against the notch pathways and uses thereof
|
|
AU2009248049B2
(en)
|
2008-05-16 |
2015-07-23 |
Ablynx N.V. |
Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
|
|
ES2713864T3
(es)
|
2008-06-05 |
2019-05-24 |
Ablynx Nv |
Secuencias de aminoácidos dirigidas contra proteínas de la envuelta de un virus y polipéptidos que comprenden las mismas para el tratamiento de enfermedades virales
|
|
MX344076B
(es)
|
2008-06-30 |
2016-12-05 |
Esbatech Alcon Biomed Res Unit |
Polipeptidos funcionalizados.
|
|
US8697074B2
(en)
|
2008-07-10 |
2014-04-15 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Methods and compositions for enhanced delivery of macromolecules
|
|
JP5806112B2
(ja)
*
|
2008-07-18 |
2015-11-10 |
トリニティー セラピューティクス インコーポレイテッド |
デング出血熱およびデングショック症候群を含む免疫介在性デング熱感染症およびデング熱感染症の抗体依存性増強を処置するための方法
|
|
LT2334705T
(lt)
|
2008-09-26 |
2017-03-27 |
Ucb Biopharma Sprl |
Biologiniai produktai
|
|
WO2010046357A1
(en)
|
2008-10-21 |
2010-04-29 |
Novo Nordisk A/S |
Amylin derivatives
|
|
KR20110079693A
(ko)
|
2008-10-29 |
2011-07-07 |
와이어쓰 엘엘씨 |
단일 도메인 항원 결합 분자의 정제 방법
|
|
EP2362767B1
(en)
|
2008-10-29 |
2017-12-06 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
|
WO2010054699A1
(en)
*
|
2008-11-17 |
2010-05-20 |
Affibody Ab |
Conjugates of albumin binding domain
|
|
AR074203A1
(es)
|
2008-11-22 |
2010-12-29 |
Genentech Inc |
Terapia anti-angiogenesis para el tratamiento del cancer de mama. kit. uso.
|
|
DK2370465T3
(da)
|
2008-12-19 |
2019-05-06 |
Ablynx Nv |
Genetisk immunisering til fremstilling af immunoglobuliner mod celleassocierede antigener, såsom p2x7, cxcr7 eller cxcr4
|
|
US8648046B2
(en)
|
2009-02-26 |
2014-02-11 |
Oncolix, Inc. |
Compositions and methods for visualizing and eliminating cancer stem cells
|
|
WO2010099003A2
(en)
|
2009-02-26 |
2010-09-02 |
Oncolix, Inc. |
Compositions and methods for visualizing and eliminating cancer stem cells
|
|
EP3702371B1
(en)
|
2009-03-25 |
2022-11-02 |
Genentech, Inc. |
Anti-fgfr3 antibodies and methods using same
|
|
KR20120057565A
(ko)
|
2009-04-01 |
2012-06-05 |
제넨테크, 인크. |
항-ＦｃＲＨ５ 항체 및 면역접합체 및 사용 방법
|
|
AU2010233658B2
(en)
|
2009-04-10 |
2013-11-28 |
Ablynx Nv |
Improved amino acid sequences directed against IL-6R and polypeptides comprising the same for the treatment of IL-6R related diseases and disorders
|
|
EP2438087B1
(en)
|
2009-06-05 |
2017-05-10 |
Ablynx N.V. |
Trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections
|
|
BR112012003346A2
(pt)
|
2009-08-15 |
2016-11-16 |
Genentech Inc |
metodo de tratamento de um paciente diagnostico com cancer de mama metastico previamente tratado kit para tratamento de cancer de mama metastatico previamente tratado em um paciente humano metodo para instruir um paciente humano com cancer metodo promocional e metodo comercial
|
|
CA2809819A1
(en)
|
2009-09-09 |
2011-03-17 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
|
GB201005063D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
JP5814925B2
(ja)
|
2009-10-22 |
2015-11-17 |
ジェネンテック， インコーポレイテッド |
抗ヘプシン抗体及びその使用方法
|
|
CN105274170A
(zh)
|
2009-11-05 |
2016-01-27 |
弗·哈夫曼-拉罗切有限公司 |
分泌异源多肽的方法和组合物
|
|
HUE029454T2
(en)
|
2009-11-13 |
2017-03-28 |
Grifols Therapeutics Inc |
Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
|
|
WO2011064382A1
(en)
|
2009-11-30 |
2011-06-03 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
|
MX2012006406A
(es)
|
2009-12-04 |
2012-07-25 |
Genentech Inc |
Anticuerpos multiespecificos, analogos de anticuerpo, composiciones y metodos.
|
|
EP2509997B1
(en)
|
2009-12-07 |
2017-08-30 |
i2 Pharmaceuticals, Inc. |
Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
|
|
RS67588B1
(sr)
|
2009-12-14 |
2026-01-30 |
Ablynx Nv |
Antitela sa pojedinačnim varijabilnim domenom imunoglobulina protiv ox40l, konstrukti i njihova terapijska upotreba
|
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
|
CN110227154A
(zh)
|
2010-02-23 |
2019-09-13 |
霍夫曼-拉罗奇有限公司 |
用于治疗卵巢癌的抗血管发生疗法
|
|
US8937164B2
(en)
|
2010-03-26 |
2015-01-20 |
Ablynx N.V. |
Biological materials related to CXCR7
|
|
WO2011130598A1
(en)
|
2010-04-15 |
2011-10-20 |
Spirogen Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
AU2011254557B2
(en)
|
2010-05-20 |
2015-09-03 |
Ablynx Nv |
Biological materials related to HER3
|
|
WO2011153243A2
(en)
|
2010-06-02 |
2011-12-08 |
Genentech, Inc. |
Anti-angiogenesis therapy for treating gastric cancer
|
|
NZ701208A
(en)
|
2010-06-03 |
2016-05-27 |
Genentech Inc |
Immuno-pet imaging of antibodies and immunoconjugates and uses thereof
|
|
MX336540B
(es)
|
2010-06-08 |
2016-01-22 |
Genentech Inc |
Conjugados y anticuerpos manipulados geneticamente con cisteina.
|
|
WO2012004384A2
(en)
|
2010-07-09 |
2012-01-12 |
Affibody Ab |
Polypeptides
|
|
EA201390450A1
(ru)
|
2010-09-28 |
2013-07-30 |
Амилин Фармасьютикалс, Ллк. |
Полипептиды с увеличенной продолжительностью действия
|
|
WO2012042026A1
(en)
|
2010-09-30 |
2012-04-05 |
Ablynx Nv |
Biological materials related to c-met
|
|
JP5933573B2
(ja)
|
2010-11-08 |
2016-06-15 |
ノバルティス アーゲー |
Ｃｘｃｒ２結合ポリペプチド
|
|
ES2544608T3
(es)
|
2010-11-17 |
2015-09-02 |
Genentech, Inc. |
Conjugados de anticuerpo y de alaninil-maitansinol
|
|
EP2643349B1
(en)
|
2010-11-26 |
2019-09-04 |
Molecular Partners AG |
Designed repeat proteins binding to serum albumin
|
|
US20120213781A1
(en)
|
2011-02-11 |
2012-08-23 |
Zyngenia, Inc. |
Monovalent and Multivalent Multispecific Complexes and Uses Thereof
|
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
|
MX2013013054A
(es)
|
2011-05-12 |
2014-02-20 |
Genentech Inc |
Metodo de monitoreo de lc-ms/ms de reaccion multiple para detectar anticuerpos terapeuticos en muestras de animales utilizando peptidos de firma de estructura.
|
|
CN108329391A
(zh)
|
2011-05-27 |
2018-07-27 |
埃博灵克斯股份有限公司 |
使用rankl结合肽抑制骨质吸收
|
|
AU2012273928A1
(en)
|
2011-06-23 |
2014-02-06 |
Ablynx Nv |
Immunoglobulin single variable domains directed against IgE
|
|
BR112013030472A2
(pt)
|
2011-06-30 |
2019-09-24 |
Genentech Inc |
formulação farmacêutica, artigo de fabricação e método
|
|
RU2014103288A
(ru)
|
2011-07-01 |
2015-08-10 |
Байер Интеллектчуал Проперти Гмбх |
Слитые полипептиды релаксина и их применение
|
|
KR20140039257A
(ko)
|
2011-07-08 |
2014-04-01 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
릴랙신을 방출하는 융합 단백질 및 이의 용도
|
|
US20130022551A1
(en)
|
2011-07-22 |
2013-01-24 |
Trustees Of Boston University |
DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS
|
|
EP2749646B1
(en)
*
|
2011-08-24 |
2018-03-21 |
Kagoshima University |
IgG-BINDING PEPTIDE AND METHOD FOR DETECTING AND PURIFYING IgG USING SAME
|
|
CA2849409A1
(en)
|
2011-09-23 |
2013-03-28 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Anti-tumor necrosis factor-alpha agents and uses thereof
|
|
US20150044208A1
(en)
|
2011-09-23 |
2015-02-12 |
Technophage, Investigaçäo E Desenvolvimento Em Biotecnologia, Sa |
Modified Albumin-Binding Domains and Uses Thereof to Improve Pharmacokinetics
|
|
US10138302B2
(en)
|
2011-09-23 |
2018-11-27 |
Ablynx N.V. |
Methods for treating rheumatoid arthritis by administering interleukin-6 receptor antibodies
|
|
CN106046161B
(zh)
|
2011-09-30 |
2019-09-13 |
埃博灵克斯股份有限公司 |
与C-Met相关的生物物质
|
|
WO2013055987A1
(en)
|
2011-10-14 |
2013-04-18 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
SI2776466T1
(sl)
|
2011-11-11 |
2017-12-29 |
Ucb Biopharma Sprl |
Protitelesa, ki se vežejo na albumin in njihovi vezavni fragmenti
|
|
MX353382B
(es)
|
2012-03-01 |
2018-01-10 |
Amgen Res Munich Gmbh |
Moleculas de union polipeptido de larga duracion.
|
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
|
KR20140142298A
(ko)
*
|
2012-03-28 |
2014-12-11 |
애피바디 에이비 |
경구투여
|
|
JP2020033372A
(ja)
*
|
2012-03-28 |
2020-03-05 |
アフィボディ・アーベー |
経口投与
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
US8822423B2
(en)
*
|
2012-05-17 |
2014-09-02 |
Janssen Biotech, Inc. |
Affinity peptides toward infliximab
|
|
WO2013172967A1
(en)
|
2012-05-17 |
2013-11-21 |
Extend Biosciences, Inc |
Carriers for improved drug delivery
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
US9156887B2
(en)
|
2012-05-25 |
2015-10-13 |
Janssen Biotech, Inc. |
Non-natural consensus albumin binding domains
|
|
US9856314B2
(en)
|
2012-06-22 |
2018-01-02 |
Cytomx Therapeutics, Inc. |
Activatable antibodies having non-binding steric moieties and methods of using the same
|
|
US20150191506A1
(en)
*
|
2012-06-29 |
2015-07-09 |
Asahi Kasei Medical Co., Ltd. |
Adsorbent consisting of carrier which bound with polypeptide comprising b-domain mutant derived from protein a
|
|
WO2014048977A1
(en)
|
2012-09-25 |
2014-04-03 |
Affibody Ab |
Albumin binding polzpeptide
|
|
WO2014057117A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
HRP20190366T1
(hr)
|
2012-10-12 |
2019-04-19 |
Medimmune Limited |
Pirolobenzodiazepini i njihovi konjugati
|
|
PL2906251T3
(pl)
|
2012-10-12 |
2018-02-28 |
Adc Therapeutics Sa |
Koniugaty pirolobenzodiazepina-przeciwciało anty-CD22
|
|
KR101645905B1
(ko)
|
2012-10-12 |
2016-08-04 |
스피로즌 살 |
피롤로벤조디아제핀 및 그의 컨주게이트
|
|
WO2014057120A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
MX364328B
(es)
|
2012-10-12 |
2019-04-23 |
Medimmune Ltd |
Conjugados del anticuerpo pirrolobenzodiazepina.
|
|
ES2680153T3
(es)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
|
|
HRP20181646T2
(hr)
|
2012-10-12 |
2019-08-09 |
Adc Therapeutics Sa |
Konjugati pirolobenzodiazepin - anti-psma protutijela
|
|
PL2912051T3
(pl)
|
2012-10-25 |
2018-08-31 |
Affibody Ab |
Sposób rozdzielania białek zawierających domenę wiążącą albuminę
|
|
ES2639099T3
(es)
|
2012-10-25 |
2017-10-25 |
Affibody Ab |
Polipéptido de unión a albúmina
|
|
CN105246894A
(zh)
|
2012-12-21 |
2016-01-13 |
斯皮罗根有限公司 |
用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
|
|
AU2013366493B2
(en)
|
2012-12-21 |
2017-08-24 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP2752426A1
(en)
|
2013-01-03 |
2014-07-09 |
Covagen AG |
Human serum albumin binding compounds and fusion proteins thereof
|
|
JP6363022B2
(ja)
|
2013-01-28 |
2018-07-25 |
国立研究開発法人産業技術総合研究所 |
抗体結合性ペプチド
|
|
EP2968587A2
(en)
|
2013-03-13 |
2016-01-20 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
|
|
JP6445519B2
(ja)
|
2013-03-13 |
2018-12-26 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピン及びそのコンジュゲート
|
|
EP2968585B1
(en)
|
2013-03-13 |
2018-07-18 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2014140862A2
(en)
|
2013-03-13 |
2014-09-18 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
SI2970449T1
(sl)
|
2013-03-15 |
2019-11-29 |
Amgen Res Munich Gmbh |
Enoverižne vezavne molekule, ki vsebujejo N-terminalni ABP
|
|
US10442836B2
(en)
|
2013-08-12 |
2019-10-15 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
EP3054986B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US9950078B2
(en)
|
2013-10-11 |
2018-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CA2928952A1
(en)
|
2013-12-16 |
2015-06-25 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
|
BR112016013258A2
(pt)
|
2013-12-16 |
2018-01-16 |
Genentech Inc |
composto conjugado anticorpo-droga, composição farmacêutica, método para tratar câncer e kit
|
|
JP6895254B2
(ja)
|
2013-12-16 |
2021-06-30 |
ジェネンテック， インコーポレイテッド |
ペプチド模倣化合物及びその抗体−薬物コンジュゲート
|
|
US10167322B2
(en)
|
2013-12-20 |
2019-01-01 |
Affibody Ab |
Engineered albumin binding polypeptide
|
|
WO2015132248A2
(en)
*
|
2014-03-03 |
2015-09-11 |
Vrije Universiteit Brussel (Vub) |
Sequamers - a novel non-natural type of peptide libraries randomly constrained by their primary sequences
|
|
BR112016020822A2
(pt)
|
2014-03-14 |
2017-10-03 |
Genentech Inc |
Métodos e composições para secreção de polipeptídeos heterólogos
|
|
BR112016021383A2
(pt)
|
2014-03-24 |
2017-10-03 |
Genentech Inc |
Método para identificar um paciente com câncer que é susceptível ou menos susceptível a responder ao tratamento com um antagonista de cmet, método para identificar um paciente apresentando câncer previamente tratado, método para determinar a expressão do biomarcador hgf, antagonista anti-c-met e seu uso, kit de diagnóstico e seu método de preparo
|
|
EP2940128A1
(en)
|
2014-04-30 |
2015-11-04 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Adenovirus comprising an albumin-binding moiety
|
|
SG10201913507SA
(en)
|
2014-05-02 |
2020-02-27 |
Momenta Pharmaceuticals Inc |
Compositions and methods related to engineered fc constructs
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
WO2016037644A1
(en)
|
2014-09-10 |
2016-03-17 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US10149913B2
(en)
|
2014-09-12 |
2018-12-11 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
|
US10077318B2
(en)
|
2014-09-12 |
2018-09-18 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
JP2017533887A
(ja)
|
2014-09-17 |
2017-11-16 |
ジェネンテック， インコーポレイテッド |
ピロロベンゾジアゼピン類及びその抗体ジスルフィドコンジュゲート
|
|
DK3262071T3
(da)
|
2014-09-23 |
2020-06-15 |
Hoffmann La Roche |
Fremgangsmåde til anvendelse af anti-CD79b-immunkonjugater
|
|
US9789197B2
(en)
|
2014-10-22 |
2017-10-17 |
Extend Biosciences, Inc. |
RNAi vitamin D conjugates
|
|
US9585934B2
(en)
|
2014-10-22 |
2017-03-07 |
Extend Biosciences, Inc. |
Therapeutic vitamin D conjugates
|
|
WO2016065052A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Insulin vitamin d conjugates
|
|
RU2017119185A
(ru)
|
2014-11-05 |
2018-12-05 |
Дженентек, Инк. |
Антитела против fgfr2/3 и способы их применения
|
|
US10780096B2
(en)
|
2014-11-25 |
2020-09-22 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CA2969689A1
(en)
|
2014-12-03 |
2016-06-09 |
Genentech, Inc. |
Quaternary amine compounds and antibody-drug conjugates thereof
|
|
USRE49529E1
(en)
|
2014-12-19 |
2023-05-16 |
Inozyme Pharma, Inc. |
Methods of treating tissue calcification
|
|
WO2016156570A1
(en)
|
2015-04-02 |
2016-10-06 |
Ablynx N.V. |
Bispecific cxcr4-cd-4 polypeptides with potent anti-hiv activity
|
|
WO2016161388A1
(en)
|
2015-04-03 |
2016-10-06 |
University Of Massachusetts |
Fully stabilized asymmetric sirna
|
|
PH12017501834B1
(en)
|
2015-04-06 |
2024-01-17 |
Arcellx Inc |
De novo binding domain containing polypeptides and uses thereof
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
ES2754427T3
(es)
|
2015-05-13 |
2020-04-17 |
Ablynx Nv |
Polipéptidos de reclutamiento de células T basados en la reactividad de TCR alfa/beta
|
|
PL3294319T3
(pl)
|
2015-05-13 |
2024-10-07 |
Ablynx Nv |
Polipeptydy rekrutujące komórki t na podstawie reaktywności cd3
|
|
ES2784603T3
(es)
|
2015-06-02 |
2020-09-29 |
Novo Nordisk As |
Insulinas con extensiones recombinantes polares
|
|
EP3334499A4
(en)
|
2015-08-14 |
2019-04-17 |
University of Massachusetts |
BIOACTIVE CONJUGATES FOR THE RELEASE OF OLIGONUCLEOTIDES
|
|
EP3355931B1
(en)
|
2015-10-01 |
2024-06-26 |
Novo Nordisk A/S |
Protein conjugates
|
|
CN108137651B
(zh)
*
|
2015-10-23 |
2022-02-22 |
富士胶片株式会社 |
环肽、亲和层析载体、标记抗体、抗体药物复合物及药物制剂
|
|
AU2016360987A1
(en)
|
2015-11-27 |
2018-06-07 |
Ablynx Nv |
Polypeptides inhibiting CD40L
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
US10478503B2
(en)
|
2016-01-31 |
2019-11-19 |
University Of Massachusetts |
Branched oligonucleotides
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
CN109153711B
(zh)
|
2016-03-01 |
2022-04-26 |
伊利诺伊大学理事会 |
具有降低的l-谷氨酰胺酶活性和增强的稳定性的l-天冬酰胺酶变体和融合蛋白
|
|
ES2972740T3
(es)
|
2016-03-02 |
2024-06-14 |
Momenta Pharmaceuticals Inc |
Procedimientos relacionados con construcciones de Fc modificadas genéticamente
|
|
EP3433621A1
(en)
|
2016-03-25 |
2019-01-30 |
H. Hoffnabb-La Roche Ag |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
|
CN115184315A
(zh)
|
2016-04-15 |
2022-10-14 |
伯克利之光生命科技公司 |
用于坞内测定的方法、系统和试剂盒
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
PL3484514T3
(pl)
|
2016-05-23 |
2024-04-29 |
Momenta Pharmaceuticals, Inc. |
Kompozycje i sposoby związane z projektowanymi konstruktami Fc
|
|
US20170370906A1
(en)
|
2016-05-27 |
2017-12-28 |
Genentech, Inc. |
Bioanalytical analysis of site-specific antibody drug conjugates
|
|
EP3463430B1
(en)
*
|
2016-06-03 |
2025-01-01 |
Janssen Biotech, Inc. |
Serum albumin-binding fibronectin type iii domains
|
|
EP3827835A1
(en)
|
2016-06-16 |
2021-06-02 |
Inozyme Pharma, Inc. |
Methods of treating myointimal proliferation
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
WO2018031933A2
(en)
|
2016-08-12 |
2018-02-15 |
University Of Massachusetts |
Conjugated oligonucleotides
|
|
WO2018043629A1
(ja)
|
2016-09-01 |
2018-03-08 |
国立研究開発法人産業技術総合研究所 |
非天然型立体構造を形成した抗体に親和性を示すポリペプチド
|
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
EP3521300A4
(en)
*
|
2016-09-30 |
2019-12-25 |
FUJIFILM Corporation |
CYCLIC PEPTIDE, AFFINITY CHROMATOGRAPHY CARRIER, MARKED ANTIBODY, ANTIBODY-ACTIVE SUBSTANCE CONJUGATE AND PHARMACEUTICAL PREPARATION
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
CN110461880A
(zh)
|
2016-11-10 |
2019-11-15 |
科乐斯疗法公司 |
Gdnf融合多肽及其使用方法
|
|
CA3043515A1
(en)
|
2016-11-16 |
2018-05-24 |
Ablynx Nv |
T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta
|
|
BR112019013955A2
(pt)
|
2017-01-06 |
2020-02-11 |
Momenta Pharmaceuticals, Inc. |
Composições e métodos relacionados a construtos de fc manipulados
|
|
UA125198C2
(uk)
|
2017-02-08 |
2022-01-26 |
Ейдісі Терапьютікс Са |
Кон'югати піролобензодіазепін-антитіло
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP2020513019A
(ja)
|
2017-04-05 |
2020-04-30 |
ノヴォ ノルディスク アー／エス |
オリゴマー伸長インスリン−Ｆｃコンジュゲート
|
|
SI3612537T1
(sl)
|
2017-04-18 |
2022-10-28 |
Medimmune Limited |
Konjugati pirolobenzodiazepina
|
|
WO2018193102A1
(en)
|
2017-04-20 |
2018-10-25 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate
|
|
KR20240046307A
(ko)
|
2017-04-28 |
2024-04-08 |
아지노모토 가부시키가이샤 |
가용성 단백질에 대한 친화성 물질, 절단성 부분 및 반응성기를 갖는 화합물 또는 이의 염
|
|
WO2018220225A1
(en)
|
2017-06-02 |
2018-12-06 |
Ablynx Nv |
Aggrecan binding immunoglobulins
|
|
BR112019024333A2
(pt)
|
2017-06-02 |
2020-07-28 |
Merck Patent Gmbh |
imunoglobulinas de ligação adamts
|
|
WO2018220235A1
(en)
|
2017-06-02 |
2018-12-06 |
Merck Patent Gmbh |
Mmp13 binding immunoglobulins
|
|
US11813307B2
(en)
|
2017-06-02 |
2023-11-14 |
Merck Patent Gmbh |
Polypeptides binding ADAMTS5, MMP13 and aggrecan
|
|
JP7145891B2
(ja)
|
2017-06-14 |
2022-10-03 |
アーデーセー セラピューティクス ソシエテ アノニム |
抗ｃｄ１９ ａｄｃを投与するための投与レジメ
|
|
CN110799647A
(zh)
|
2017-06-23 |
2020-02-14 |
马萨诸塞大学 |
双尾自递送sirna及相关的方法
|
|
IL307197B1
(en)
|
2017-07-11 |
2025-11-01 |
Alexion Pharma Inc |
Polypeptides that bind complement component c5 or serum albumin and fusion proteins thereof
|
|
WO2019032827A1
(en)
*
|
2017-08-09 |
2019-02-14 |
Massachusetts Institute Of Technology |
PEPTIDE ALBUMIN BINDING CONJUGATES AND METHODS THEREOF
|
|
CN111050784B
(zh)
|
2017-08-11 |
2024-03-19 |
伊利诺伊大学理事会 |
截短的豚鼠l-天冬酰胺酶变体及其使用方法
|
|
BR112020003003A2
(pt)
|
2017-08-18 |
2020-08-11 |
Medimmune Limited |
conjugados de pirrolobenzodiazepina
|
|
WO2019067502A1
(en)
|
2017-09-27 |
2019-04-04 |
Alexion Pharmaceuticals, Inc. |
METHODS FOR IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING RECOMBINANT ECTO-NUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE
|
|
PE20200849A1
(es)
|
2017-10-10 |
2020-08-20 |
Numab Therapeutics AG |
Anticuerpo multiespecifico
|
|
WO2019075476A2
(en)
|
2017-10-15 |
2019-04-18 |
Berkeley Lights, Inc. |
METHODS, SYSTEMS AND KITS FOR ENCLOSED TESTS
|
|
MX2020004933A
(es)
|
2017-11-14 |
2021-01-08 |
Arcellx Inc |
Polipéptidos que contienen dominios d y sus usos.
|
|
CN111511383A
(zh)
|
2017-11-14 |
2020-08-07 |
阿奇利克斯股份有限公司 |
多功能免疫细胞疗法
|
|
WO2019107962A2
(ko)
*
|
2017-11-29 |
2019-06-06 |
아주대학교 산학협력단 |
항체와 생리활성물질의 접합방법
|
|
KR102037336B1
(ko)
*
|
2017-11-29 |
2019-10-29 |
아주대학교산학협력단 |
항체와 생리활성물질의 접합방법
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
KR102880460B1
(ko)
|
2018-06-14 |
2025-11-06 |
아지노모토 가부시키가이샤 |
항체에 대한 친화성 물질 및 생체 직교성 관능기를 갖는 화합물 또는 이의 염
|
|
EP3806889A4
(en)
|
2018-06-18 |
2022-07-13 |
Anwita Biosciences, Inc. |
CYTOKI FUSION PROTEINS AND USES THEREOF
|
|
AU2019316640B2
(en)
|
2018-08-10 |
2026-03-12 |
University Of Massachusetts |
Modified oligonucleotides targeting SNPs
|
|
EP3840759A4
(en)
|
2018-08-23 |
2022-06-01 |
University Of Massachusetts |
O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES
|
|
US20220002370A1
(en)
|
2018-09-27 |
2022-01-06 |
Xilio Development, Inc. |
Masked cytokine polypeptides
|
|
EP3882261A4
(en)
|
2018-10-31 |
2023-02-08 |
Ajinomoto Co., Inc. |
COMPOUND COMPRISING A SUBSTANCE HAVING AN AFFINITY FOR AN ANTIBODY, CLEAVAGE SITE AND CORRESPONDING REACTIVE GROUP OR SALT
|
|
EP3894427A1
(en)
|
2018-12-10 |
2021-10-20 |
Genentech, Inc. |
Photocrosslinking peptides for site specific conjugation to fc-containing proteins
|
|
AU2019403458A1
(en)
*
|
2018-12-20 |
2021-06-10 |
Kleo Pharmaceuticals, Inc. |
Combination therapy of arms and natural killer cells
|
|
AU2020207935A1
(en)
|
2019-01-18 |
2021-08-26 |
University Of Massachusetts |
Dynamic pharmacokinetic-modifying anchors
|
|
MX2021010477A
(es)
|
2019-03-15 |
2021-10-01 |
Medimmune Ltd |
Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer.
|
|
KR20220047989A
(ko)
|
2019-08-09 |
2022-04-19 |
유니버시티 오브 매사추세츠 |
Snp를 표적화하는 화학적으로 변형된 올리고뉴클레오타이드
|
|
US12365894B2
(en)
|
2019-09-16 |
2025-07-22 |
University Of Massachusetts |
Branched lipid conjugates of siRNA for specific tissue delivery
|
|
EP3816185A1
(en)
|
2019-11-04 |
2021-05-05 |
Numab Therapeutics AG |
Multispecific antibody directed against pd-l1 and a tumor-associated antigen
|
|
EP4076505A4
(en)
|
2019-12-18 |
2024-01-24 |
ARO Biotherapeutics Company |
SERUM ALBUM BINDING FIBRONECTIN TYPE III DOMAIN AND USES THEREOF
|
|
GB201919061D0
(en)
|
2019-12-20 |
2020-02-05 |
Ucb Biopharma Sprl |
Multi-specific antibody
|
|
CA3170874A1
(en)
|
2020-03-09 |
2021-09-16 |
Phillip J. M. ELMS |
Methods, systems and kits for in-pen assays
|
|
US12534724B2
(en)
|
2020-05-26 |
2026-01-27 |
University Of Massachusetts |
Synthetic oligonucleotides having regions of block and cluster modifications
|
|
EP3915580A1
(en)
|
2020-05-29 |
2021-12-01 |
Numab Therapeutics AG |
Multispecific antibody
|
|
WO2022004805A1
(ja)
|
2020-06-30 |
2022-01-06 |
株式会社ガイアバイオメディシン |
Ｎｋ細胞と抗体との結合を安定化する方法、及びその利用
|
|
EP3988568A1
(en)
|
2020-10-21 |
2022-04-27 |
Numab Therapeutics AG |
Combination treatment
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
EP4255926A1
(en)
|
2020-12-07 |
2023-10-11 |
UCB Biopharma SRL |
Multi-specific antibodies and antibody combinations
|
|
KR20230166075A
(ko)
|
2021-02-02 |
2023-12-06 |
누맙 세러퓨틱스 아게 |
Ror1 및 cd3에 대한 특이성을 가지는 다중 특이적 항체
|
|
AU2022224636A1
(en)
|
2021-02-19 |
2023-09-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies that neutralize sars-cov-2
|
|
IL306096A
(en)
|
2021-03-26 |
2023-11-01 |
Arcellx Inc |
Multifunctional immune cell therapies
|
|
IL309334A
(en)
|
2021-06-23 |
2024-02-01 |
Univ Massachusetts |
Anti-FLT1 optimized oligonucleotide compounds for the treatment of preeclampsia and other angiogenic disorders
|
|
EP4183800A1
(en)
|
2021-11-19 |
2023-05-24 |
Medizinische Hochschule Hannover |
Novel sars-cov-2 neutralizing antibodies
|
|
KR20230132640A
(ko)
|
2022-03-04 |
2023-09-15 |
앱티스 주식회사 |
티올 반응성 에디티브를 이용한 항체-약물 컨쥬게이트의 제조 수율을 높이는 방법
|
|
AU2023279467A1
(en)
|
2022-06-02 |
2025-01-16 |
Ajinomoto Co., Inc. |
Affinity substance, compound, and antibody and their salts
|
|
AU2023303873A1
(en)
|
2022-07-08 |
2025-01-02 |
Novo Nordisk A/S |
Highly potent isvd compounds capable of substituting for fviii(a)
|
|
WO2024038095A1
(en)
|
2022-08-16 |
2024-02-22 |
Iome Bio |
NOVEL ANTI-RGMb ANTIBODIES
|
|
US12233115B2
(en)
|
2022-09-30 |
2025-02-25 |
Extend Biosciences, Inc. |
Long-acting parathyroid hormone
|
|
WO2024083843A1
(en)
|
2022-10-18 |
2024-04-25 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
|
AU2024277146A1
(en)
*
|
2023-05-22 |
2025-11-27 |
Kaida Biopharmaceuticals, Inc. |
Antagonist fusion polypeptides
|
|
WO2025019077A1
(en)
|
2023-07-18 |
2025-01-23 |
Nanotein Technologies, Inc. |
Reagents, reagent kits, and culture media for activating and expanding immune cells and uses thereof
|
|
US12377158B1
(en)
*
|
2024-07-05 |
2025-08-05 |
Michael Farber |
Enhanced peptide constructs for albumin binding
|